Last reviewed · How we verify
NCT01182870
Vitamin D and the Influenza Epidemic
Phase 3 trial testing choleclaciferol in Influenza in 569 participants. Completed in 1 October 2010.
1 September 2010
Quick facts
| Lead sponsor | University of Tromso |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | prevention |
| Enrollment | 569 |
| Start date | 1 April 2010 |
| Primary completion | 1 September 2010 |
| Estimated completion | 1 October 2010 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- choleclaciferol — full drug profile →
Conditions studied
- Influenza — all drugs for Influenza →
Sponsor
University of Tromso
Who can join
Adults 20 to 80, any sex, with Influenza. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
influenza during the winter season 2009/2010
Time frame: up to 30 weeks
Sponsor's own description
Subjects included in ongoing vitamin d intervention trials were asked by questionnaire if they were ill with influenza during the winter season 2009/2010 to see if vitamin d supplementation prevented flu like disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT01182870
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Influenza
Currently open trials in the same condition.
- NCT07215858 — BPL-1357 Against H1N1 Influenza Virus Challenge · Phase 2 · recruiting
- NCT07496450 — A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults · Phase 3 · recruiting
- NCT07302256 — A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above · Phase 1 · recruiting
- NCT07431840 — Immune Defense Protein Impact On Respiratory Immune Outcomes · NA · recruiting
- NCT07485855 — Influenza Vaccination Strategy for Patients With Hematologic Malignancy · Phase 3 · recruiting
Other University of Tromso trials
Trials by the same sponsor.
- NCT07120659 — Vacuum Massage vs Tactile Massage for the Treatment of Chronic Neck Pain · NA · recruiting
- NCT06122441 — RE-inventing Strategies for Healthy Ageing; Recommendations and Tools · NA · active not recruiting
- NCT05794945 — Optimizing Mastitis Identification and Treatment · recruiting
- NCT05398770 — Vitamin D Supplementation Prior to Non-surgical Periodontal Therapy · NA · completed
- NCT05647499 — Evaluating the Back 2 School Program in a Norwegian Setting: A Multicenter Pilot Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01182870 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Tromso
- Last refreshed: 19 July 2011
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01182870.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing